Production (Stage)
Theratechnologies Inc.
TH.TO
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,913.68% | 101.48% | -355.68% | 213.17% | 122.03% |
| Total Depreciation and Amortization | -3.67% | -0.41% | 0.82% | -61.25% | 144.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.93% | -83.58% | 2,245.63% | 30.79% | -56.05% |
| Change in Net Operating Assets | 215.42% | -199.34% | -849.26% | 118.72% | -304.50% |
| Cash from Operations | 227.29% | -4,192.51% | -104.93% | 1,687.59% | 83.02% |
| Capital Expenditure | -166.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -4,256.02% | -78.69% | 668.61% | -202.24% |
| Cash from Investing | 99.88% | -4,257.83% | -78.69% | 668.61% | -202.24% |
| Total Debt Issued | -- | -88.89% | -- | -- | -- |
| Total Debt Repaid | -3,504.71% | 99.70% | -3,413.37% | -1,377.87% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 59.89% | -452.31% | 87.43% | -237.91% |
| Cash from Financing | -247.59% | 124.94% | -901.34% | -192.33% | -132.36% |
| Foreign Exchange rate Adjustments | 438.46% | 48.00% | -377.78% | 212.50% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.31% | 36.17% | -633.23% | 428.12% | 42.16% |